David Hoang

Q: What is David Hoang's success rate?

David Hoang currently has a success rate of 80.29864612938233.

Q: What is the average return of David Hoang's calls?

Their stock ratings have generated an average return of 28.833324175901073.

Deutsche Bank | Healthcare

David Hoang is an analyst from Deutsche Bank specializing in the Healthcare sector. Ranked #1482 out of 4672 analysts, they have issued 12 stock ratings with a success rate of 80.30% and an average return of 28.83%.

With 12 ratings to date, David Hoang is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 80.30% and an average return of 28.83%, highlighting promising potential as their track record develops further.

#1482

Out of 4672

Total Ratings

+80.30%

Success Rate

+28.83%

Average Return

Recent Ratings Analysis

SYRE

Buy

Jun 04, 2026

Target

$115.00

Current

$73.52

Performance

—

David Hoang rated SYRE as Buy on Jun 04, 2026, setting a price target of 115. Shares have remained stable near 73.52, leaving the 115 target still in play.

PRAX

Buy

Jun 02, 2026

Target

$374.00

Current

$278.93

Performance

—

On Jun 02, 2026, PRAX was given a Buy rating by David Hoang, with a target price of 374. The stock traded sideways with a % move, keeping the bullish thesis unresolved.

ATAI

Buy

Mar 27, 2026

Target

$12.00

Current

$4.53

Performance

35.22%

ATAI received a Buy rating from David Hoang on Mar 27, 2026, aiming for 12. Momentum has favored the Buy call, with shares climbing from 4.53 to 4.53, rewarding those who trusted the recommendation.

XENE

Buy

Mar 10, 2026

Target

$90.00

Current

$53.46

Performance

-11.80%

On Mar 10, 2026, David Hoang published a Buy outlook on XENE, with a target of 90. Market action contradicted the Buy thesis, as shares slipped to 53.46.

APGE

Buy

Dec 10, 2025

Target

$103.00

Current

$84.19

Performance

10.69%

David Hoang on Dec 10, 2025 assigned APGE a Buy rating, with a price target of 103. The Buy call aligned well with market performance, producing a gain of 10.69%.

ALKS

Buy

Nov 13, 2025

Target

$45.00

Current

$42.76

Performance

37.89%

On Nov 13, 2025, David Hoang reaffirmed ALKS with a Buy rating, targeting 45. The recommendation was supported by strong follow-through as the stock rose from 42.76 to 42.76.

HRMY

Buy

Sep 25, 2025

Target

$36.00

Current

$32.10

Performance

18.71%

HRMY was rated Buy by David Hoang on Sep 25, 2025, with a price objective of 36. A bullish response from the market helped close the gap of 3.90 to the target.

SRPT

Sell

Aug 15, 2025

Target

$12.00

Current

$16.24

Performance

-25.54%

On Aug 15, 2025, David Hoang initiated coverage on SRPT with a Sell rating and target of 12. Shares gained despite the bearish call, moving higher from 16.24.

DNLI

Buy

Feb 11, 2025

Target

$31.00

Current

$19.66

Performance

-4.47%

David Hoang issued a Buy recommendation for DNLI on Feb 11, 2025, price target set at 31. The target of 31 remains in play, though confirmation will depend on future moves.

AVDL

Buy

Feb 11, 2025

Target

$12.00

Current

$21.64

Performance

140.44%

On Feb 11, 2025, AVDL was evaluated by David Hoang, who gave a Buy rating and target of 12. This case illustrates how a timely bullish rating can translate into tangible gains of 140.44%.

AXSM

Buy

Feb 11, 2025

Target

$176.00

Current

$233.49

Performance

76.62%

David Hoang rated AXSM as Buy on Feb 11, 2025, setting a price target of 176. The call has proven timely, with shares rising 76.62% toward the price target of 176.

BHVN

Buy

Feb 11, 2025

Target

$65.00

Current

$10.81

Performance

-74.58%

On Feb 11, 2025, BHVN was given a Buy rating by David Hoang, with a target price of 65. Despite the Buy call, shares fell from 10.81 to 10.81, challenging the optimistic stance.

NBIX

Hold

Aug 02, 2024

Target

$158.00

Current

$165.11

Performance

7.82%

NBIX received a Neutral rating from David Hoang on Aug 02, 2024, aiming for 158. Investors saw gains of 7.82% that the cautious stance didn’t fully capture.

LBPH

Buy

Aug 02, 2024

Target

$50.00

Current

$59.98

Performance

82.59%

On Aug 02, 2024, David Hoang published a Buy outlook on LBPH, with a target of 50. Shares gained 82.59%, underscoring the accuracy of the bullish outlook toward 50.

ABOS

Buy

Jul 25, 2024

Target

$7.00

Current

$2.29

Performance

-32.84%

David Hoang on Jul 25, 2024 assigned ABOS a Buy rating, with a price target of 7. The call has struggled to gain traction, with shares losing 32.84%.

ACAD

Buy

May 09, 2024

Target

$30.00

Current

$21.43

Performance

40.89%

On May 09, 2024, David Hoang reaffirmed ACAD with a Buy rating, targeting 30. The recommendation was supported by strong follow-through as the stock rose from 21.43 to 21.43.

Frequency Asked Questions

Who is David Hoang?

David Hoang is an analyst from Deutsche Bank specializing in the Healthcare sector.

What is David Hoang's success rate?

David Hoang currently has a success rate of +80.30%.

How many ratings has David Hoang issued?

David Hoang has issued 12 stock ratings so far.

What is the average return of David Hoang's calls?

Their stock ratings have generated an average return of +28.83%.

What is David Hoang's ranking?

David Hoang is ranked #1482 out of 4672 analysts.

What types of ratings does David Hoang give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Hoang?

You can follow David Hoang by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Hoang?

Their latest rating was a Buy on SYRE issued on 2026-06-04.